Tower Research Capital (TRC)’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $369K | Buy |
13,009
+4,850
| +59% | +$138K | 0.01% | 1232 |
|
|
2025
Q1 | $241K | Sell |
8,159
-17,870
| -69% | -$528K | 0.01% | 1259 |
|
|
2024
Q4 | $757K | Buy |
26,029
+24,815
| +2,044% | +$722K | 0.02% | 795 |
|
|
2024
Q3 | $55.8K | Sell |
1,214
-16,114
| -93% | -$740K | ﹤0.01% | 2665 |
|
|
2024
Q2 | $708K | Buy |
17,328
+16,679
| +2,570% | +$681K | 0.01% | 1036 |
|
|
2024
Q1 | $16.6K | Sell |
649
-20,909
| -97% | -$534K | ﹤0.01% | 3171 |
|
|
2023
Q4 | $195K | Buy |
21,558
+18,533
| +613% | +$168K | ﹤0.01% | 2114 |
|
|
2023
Q3 | $19.3K | Sell |
3,025
-12,545
| -81% | -$80K | ﹤0.01% | 3412 |
|
|
2023
Q2 | $173K | Buy |
15,570
+8,930
| +134% | +$99K | 0.01% | 1644 |
|
|
2023
Q1 | $102K | Sell |
6,640
-11,362
| -63% | -$175K | ﹤0.01% | 1851 |
|
|
2022
Q4 | $400K | Buy |
18,002
+7,716
| +75% | +$171K | 0.02% | 830 |
|
|
2022
Q3 | $168K | Sell |
10,286
-727
| -7% | -$11.9K | ﹤0.01% | 2093 |
|
|
2022
Q2 | $160K | Buy |
11,013
+9,620
| +691% | +$140K | ﹤0.01% | 1936 |
|
|
2022
Q1 | $26K | Sell |
1,393
-3,067
| -69% | -$57.2K | ﹤0.01% | 3291 |
|
|
2021
Q4 | $106K | Buy |
4,460
+3,500
| +365% | +$83.2K | ﹤0.01% | 2185 |
|
|
2021
Q3 | $24K | Sell |
960
-5,514
| -85% | -$138K | ﹤0.01% | 3567 |
|
|
2021
Q2 | $160K | Buy |
6,474
+5,056
| +357% | +$125K | ﹤0.01% | 2086 |
|
|
2021
Q1 | $31K | Buy |
1,418
+300
| +27% | +$6.56K | ﹤0.01% | 3543 |
|
|
2020
Q4 | $29K | Sell |
1,118
-1,510
| -57% | -$39.2K | ﹤0.01% | 3604 |
|
|
2020
Q3 | $74K | Buy |
+2,628
| New | +$74K | ﹤0.01% | 3364 |
|